(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

INFLAMAZOL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

INFLAMAZOL

ST13

US500000085184222

Class

5

Filing

85184222

Registration

3991259

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

04/15/2021

Trademark type

Word

Nice classes

5

Filing date

11/23/2010

Registration date

07/05/2011

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/15/2021

Last transaction

04/15/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/02/2011

First use in commerce

05/02/2011

Drawing code

4

Owner type

03

Owner location

BRIARCLIFF MANOR, NY, US

Examiner

ANKRAH, NAAKWAMA S

Law office

L90

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Global Quality Health Inc.
Global Quality Health Inc.

Representatives

Global Quality Health Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dietary Supplements

Publications

History of USPTO decisions and trademark events.

28 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/15/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

04/15/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/15/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/15/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

01/01/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/05/2020

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

12/07/2016

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

12/07/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/07/2016

E815

TEAS SECTION 8 & 15 RECEIVED

09/27/2016

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/27/2016

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/05/2016

R.PR

REGISTERED-PRINCIPAL REGISTER

07/05/2011

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/28/2011

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

05/27/2011

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/25/2011

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/18/2011

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/16/2011

IUAF

USE AMENDMENT FILED

05/10/2011

EISU

TEAS STATEMENT OF USE RECEIVED

05/10/2011

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/10/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/15/2011

PUBO

PUBLISHED FOR OPPOSITION

03/15/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

02/05/2011

ALIE

ASSIGNED TO LIE

02/04/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/31/2011

DOCK

ASSIGNED TO EXAMINER

01/24/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/30/2010

Continuous trademark protection

Get notified about every new filing that threatens INFLAMAZOL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.